NASDAQ:NAOV - NanoVibronix Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.85
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New NanoVibronix Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NAOV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NAOV

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for NanoVibronix in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.85.
N/A
The current consensus among 0 contributing investment analysts is to n/a stock in NanoVibronix. This rating has held steady since December 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/27/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/19/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/20/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/9/2019Dawson JamesInitiated CoverageBuyLow
i
Rating by R. Wasserman at Dawson James
8/5/2016Wm SmithInitiated CoverageNot Rated$10.00N/A
i
(Data available from 4/19/2016 forward)
NanoVibronix logo
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was founded in 2003 and is based in Elmsford, New York.
Read More

Today's Range

Now: $0.85
$0.80
$0.91

50 Day Range

MA: $1.06
$0.85
$1.20

52 Week Range

Now: $0.85
$0.54
$3.50

Volume

656,782 shs

Average Volume

3,760,155 shs

Market Capitalization

$11.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of NanoVibronix?

The following Wall Street analysts have issued stock ratings on NanoVibronix in the last twelve months:
View the latest analyst ratings for NAOV.

What is the current price target for NanoVibronix?

0 Wall Street analysts have set twelve-month price targets for NanoVibronix in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for NanoVibronix in the next year.
View the latest price targets for NAOV.

What is the current consensus analyst rating for NanoVibronix?

NanoVibronix currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for NAOV.

What other companies compete with NanoVibronix?

How do I contact NanoVibronix's investor relations team?

NanoVibronix's physical mailing address is 525 Executive Blvd, Elmsford NY, 10523. The company's listed phone number is 914-233-3004 and its investor relations email address is [email protected] The official website for NanoVibronix is www.nanovibronix.com.